Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPO | P05164 | 1/20 | 0.49 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.44 |
| ▸ | MAOB | P27338 | 2/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | DRD2 | P14416 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | ERN1 | O75460 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23297253 | 0.85 | MPO (0.50) | MPOELANEMAOBMAOABCHE | |
| SCHEMBL30769413 | 0.84 | MAOB (0.48) | MPOELANEMAOBMAOA | |
| SCHEMBL27259828 | 0.82 | MAOB (0.46) | MPOELANEMAOBMAOA | |
| SCHEMBL30746172 | 0.82 | MAOB (0.46) | MPOELANEMAOBMAOA | |
| SCHEMBL30769328 | 0.81 | MPO (0.46) | MPOELANEMAOBMAOABCHE | |
| SCHEMBL23740183 | 0.78 | MAOB (0.56) | MAOBMAOA | |
| SCHEMBL6858889 | 0.77 | MPO (0.57) | MPOELANEACHE | |
| SCHEMBL27264108 | 0.77 | MAOA (0.37) | MPOELANEMAOBMAOAERN1 | |
| SCHEMBL30746112 | 0.77 | MAOA (0.37) | MPOELANEMAOBMAOAERN1 | |
| SCHEMBL5851783 | 0.76 | MAOB (0.55) | MAOBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210395282-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION OF COMPOUND CONTAINING CARBON DOUBLE BOND | GLACEUM, INC. (KR) | 2021-12-23 | — | — | US | disclosed |
| EP-3862083-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION OF COMPOUND CONTAINING CARBON DOUBLE BOND | Glaceum, Inc. (KR) | 2021-08-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210395282-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION OF COMPOUND CONTAINING CARBON DOUBLE BOND | INF2, DCX, HDHD5 | MPO 485/4885ELANE 1598/4885ABCB1 4243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.